- Home
-
Learn, develop, connect
-
Membership
RQA Community Hub
Join the community - networking, discussion and more. Open to all.
More information -
Knowledge Hub
Contribute to Quasar Magazine
Could you write an interesting article for the RQA community?
More information -
About us
News Archive
EMA - High-quality data to empower data-driven medicines regulation in the European Union
19th October 2022High-quality data to empower data-driven medicines regulation in the European Union.
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022
19th October 2022Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022
EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022
19th October 2022Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 October 2022
EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022
19th October 2022Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022
ICH - Q5A(R2) draft Guideline on Viral Safety Evaluation of Biotechnology Products reached Step 2
19th October 2022The ICH Q5A(R2) draft Guideline on Viral Safety Evaluation of Biotechnology Products reached Step 2 of the ICH process on 29 September 2022.
MHRA - Consultation on how MHRA communicate with healthcare professionals to improve medicines and medical devices’ safety
19th October 2022Consultation on how MHRA communicate with healthcare professionals to improve medicines and medical devices’ safety. Consultation description The MHRA is reviewing its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices. We want to ensure that healthcare professionals are receiving actionable information and guidance on safe use of medicines and medical devices that they can take into their working practice, providing timely advice to patients. We need to improve the way we communicate with healthcare professionals. We want to hear from you to enable us to transform how we communicate with you and how we work together on our common goal of greater patient safety. Your Participation You can participate in this consultation anonymously but if you choose to provide your email address, we will add you to our mailing list to offer you future opportunities to hear about or get involved in our work. This questionnaire will take approximately 20 minutes to complete, or longer if you wish to offer additional comments. Please note that you do not have to answer every question and compulsory questions are clearly marked. Ways to respond Respond online
MHRA - MORE Registrations - user reference guide A step-by-step guide on using the MORE Platform for Registrations for Submissions of device related incidents.
19th October 2022MORE Registrations - A step-by-step guide on using the MORE Platform for Registrations for Submissions of device related incidents.
MHRA - Mental health funding of £1.8m welcomed by MHRA and NICE to explore regulation of digital mental health tools
19th October 2022Mental health funding of £1.8m welcomed by MHRA and NICE to explore regulation of digital mental health tools
MHRA - Software and AI as a Medical Device Change Programme
19th October 2022Software and AI as a Medical Device Change Programme
MHRA - Unique opportunity for healthcare professionals to influence future MHRA safety communications and safety reporting systems
19th October 2022Unique opportunity for healthcare professionals to influence future MHRA safety communications and safety reporting systems
- Home
- Learn, develop, connect
- Membership
- Knowledge Hub
- About us